Glick has more than 35 years of experience analyzing the costs of medical therapies, especially those arising from clinical trials.
He has taught cost analysis as part of the course “Clinical Economics and Clinical Decision Making” in the epidemiology program in the School of Medicine, and also as part of the course “Cost Benefit and Cost Effectiveness Analysis in Healthcare” in the Wharton School. He has given numerous short courses at academic meetings and for the U.S. Food and Drug Administration.
Glick has published over 150 peer-reviewed articles, editorials, reviews, and book chapters. He is the lead author of the book Economic Evaluation in Clinical Trials.
You can visit his university webpage here.
Analysis of Cost Data
Data on costs typically have distributions that differ dramatically from the normal distribution. They are usually highly skewed to the right, with long heavy tails and high kurtosis, often with a preponderance of zeros. These characteristics often lead to violations...View Details